The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with concurrent chemoradiotherapy for locally recurrent esophageal cancer: A single-arm, open-label study.
 
Ruinuo Jia
No Relationships to Disclose
 
Junqian Zhang
No Relationships to Disclose
 
Yaowen Zhang
No Relationships to Disclose
 
Shuoguo Li
No Relationships to Disclose
 
Jianguang Ma
No Relationships to Disclose
 
Jun Yao
No Relationships to Disclose
 
Hong Ge
No Relationships to Disclose
 
Kefeng Guo
No Relationships to Disclose
 
Jingxia Li
No Relationships to Disclose
 
Chuntao Tian
No Relationships to Disclose
 
Zhiwei Chang
No Relationships to Disclose
 
Xiaobing Chen
No Relationships to Disclose
 
Jianzheng Wang
No Relationships to Disclose
 
Xiaohong Wang
No Relationships to Disclose
 
Anping Zheng
No Relationships to Disclose
 
Manxi Sheng
No Relationships to Disclose
 
Liuyan Li
No Relationships to Disclose
 
Lei Ni
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose